A Phase II Study of the ApoE mimetic peptide drug CN-105 to reduce Postoperative Delirium and Cognitive Dysfunction after Non-Cardiac Surgery in Older Adults and to Block their Underlying Mechanisms

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
MILES
Principal Investigator Last Name
BERGER
Awardee Organization
Awardee State
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$1,631,197
Funding Organization
Agency/Funding Organization
Funding Organization Country